2-[3-[[(3S,10R,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]propoxy]-N,N-dimethyl-3-octadeca-9,12-dienoxypropan-1-amine

C53H95NO3 — CID 90917097

IUPAC2-[3-[[(3S,10R,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]propoxy]-N,N-dimethyl-3-octadeca-9,12-dienoxypropan-1-amine
SMILESCCCCCC=CCC=CCCCCCCCCOCC(CN(C)C)OCCCO[C@H]1CC[C@@]2(C)C(=CCC3C4CCC(C(C)CCCC(C)C)[C@@]4(C)CCC32)C1
InChIInChI=1S/C53H95NO3/c1-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-37-55-42-47(41-54(7)8)57-39-26-38-56-46-33-35-52(5)45(40-46)29-30-48-50-32-31-49(44(4)28-25-27-43(2)3)53(50,6)36-34-51(48)52/h13-14,16-17,29,43-44,46-51H,9-12,15,18-28,30-42H2,1-8H3/t44?,46-,47?,48?,49?,50?,51?,52-,53+/m0/s1
InChIKeyNLZDSLZPUUIUGJ-WNNRAYMVSA-N
MW794.35 g/mol
LogP14.58
Rot. Bonds30

About 2-[3-[[(3S,10R,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]propoxy]-N,N-dimethyl-3-octadeca-9,12-dienoxypropan-1-amine

2-[3-[[(3S,10R,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]propoxy]-N,N-dimethyl-3-octadeca-9,12-dienoxypropan-1-amine (PubChem CID 90917097) has the molecular formula C53H95NO3 and a molecular weight of 794.35 g/mol. Its IUPAC name is 2-[3-[[(3S,10R,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]propoxy]-N,N-dimethyl-3-octadeca-9,12-dienoxypropan-1-amine.

Molecular Properties

Compound Name2-[3-[[(3S,10R,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]propoxy]-N,N-dimethyl-3-octadeca-9,12-dienoxypropan-1-amine
PubChem CID90917097
Molecular FormulaC53H95NO3
Molecular Weight794.35 g/mol
Exact Mass793.73
IUPAC Name2-[3-[[(3S,10R,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]propoxy]-N,N-dimethyl-3-octadeca-9,12-dienoxypropan-1-amine
SMILESCCCCCC=CCC=CCCCCCCCCOCC(CN(C)C)OCCCO[C@H]1CC[C@@]2(C)C(=CCC3C4CCC(C(C)CCCC(C)C)[C@@]4(C)CCC32)C1
InChIInChI=1S/C53H95NO3/c1-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-37-55-42-47(41-54(7)8)57-39-26-38-56-46-33-35-52(5)45(40-46)29-30-48-50-32-31-49(44(4)28-25-27-43(2)3)53(50,6)36-34-51(48)52/h13-14,16-17,29,43-44,46-51H,9-12,15,18-28,30-42H2,1-8H3/t44?,46-,47?,48?,49?,50?,51?,52-,53+/m0/s1
InChIKeyNLZDSLZPUUIUGJ-WNNRAYMVSA-N
XLogP14.58
TPSA30.93 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds30
Heavy Atoms57
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500794.35
LogP ≤ 514.58
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 2-[3-[[(3S,10R,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]propoxy]-N,N-dimethyl-3-octadeca-9,12-dienoxypropan-1-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-[[(3S,10R,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]propoxy]-N,N-dimethyl-3-octadeca-9,12-dienoxypropan-1-amine?
The IUPAC name of 2-[3-[[(3S,10R,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]propoxy]-N,N-dimethyl-3-octadeca-9,12-dienoxypropan-1-amine (CID 90917097) is 2-[3-[[(3S,10R,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]propoxy]-N,N-dimethyl-3-octadeca-9,12-dienoxypropan-1-amine.
What is the SMILES notation for 2-[3-[[(3S,10R,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]propoxy]-N,N-dimethyl-3-octadeca-9,12-dienoxypropan-1-amine?
The canonical SMILES for 2-[3-[[(3S,10R,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]propoxy]-N,N-dimethyl-3-octadeca-9,12-dienoxypropan-1-amine is CCCCCC=CCC=CCCCCCCCCOCC(CN(C)C)OCCCO[C@H]1CC[C@@]2(C)C(=CCC3C4CCC(C(C)CCCC(C)C)[C@@]4(C)CCC32)C1.
What is the InChIKey of 2-[3-[[(3S,10R,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]propoxy]-N,N-dimethyl-3-octadeca-9,12-dienoxypropan-1-amine?
The InChIKey is NLZDSLZPUUIUGJ-WNNRAYMVSA-N. The full InChI is InChI=1S/C53H95NO3/c1-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-37-55-42-47(41-54(7)8)57-39-26-38-56-46-33-35-52(5)45(40-46)29-30-48-50-32-31-49(44(4)28-25-27-43(2)3)53(50,6)36-34-51(48)52/h13-14,16-17,29,43-44,46-51H,9-12,15,18-28,30-42H2,1-8H3/t44?,46-,47?,48?,49?,50?,51?,52-,53+/m0/s1.
What are the key properties of 2-[3-[[(3S,10R,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]propoxy]-N,N-dimethyl-3-octadeca-9,12-dienoxypropan-1-amine?
2-[3-[[(3S,10R,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]propoxy]-N,N-dimethyl-3-octadeca-9,12-dienoxypropan-1-amine has a molecular weight of 794.35 g/mol, XLogP of 14.58, 30 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[[(3S,10R,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]propoxy]-N,N-dimethyl-3-octadeca-9,12-dienoxypropan-1-amine is sourced from PubChem (CID 90917097), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).